0R15 8520.0 -2.3383% 0R1E 8203.0 -0.4731% 0M69 21090.0 67.5139% 0R2V 227.04 9923.8411% 0QYR None None% 0QYP 411.37 -3.2071% 0RUK 2652.0 -9.2402% 0RYA 1520.0 -2.8754% 0RIH 174.55 -1.3563% 0RIH 164.85 -5.5571% 0R1O 200.44 9897.0075% 0R1O None None% 0QFP None None% 0M2Z 267.777 -0.1763% 0VSO 32.05 -9.9846% 0R1I None None% 0QZI 559.0 0.7207% 0QZ0 220.0 0.0% 0NZF None None% 0YXG 164.23 1.7817%

Medical Properties Trust Inc.

GB 0JZZ

4.26GBP
0.12(3.02%)

Last update at 2024-11-21T15:54:00Z

Day Range

4.224.30
LowHigh

52 Week Range

3.9212.32
LowHigh

Fundamentals

  • Previous Close 4.13
  • Market Cap1937.44M
  • Volume19720
  • P/E Ratio0.03
  • Dividend Yield21.10%
  • EBITDA906.54M
  • Revenue TTM1420.70M
  • Revenue Per Share TTM2.38
  • Gross Profit TTM 1537.95M
  • Diluted EPS TTM1.89

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 959.72M 730.89M 463.33M 373.78M 1019.40M
Minority interest - - 5.33M 0.11M 13.83M
Net income 901.00M 653.86M 429.35M 372.38M 1016.68M
Selling general administrative 154.02M 141.24M 131.66M 96.41M 80.09M
Selling and marketing expenses 6.47M 4.39M - - -
Gross profit 1537.95M 1534.06M 1244.77M 846.26M 775.28M
Reconciled depreciation - - - - -
Ebit 1044.48M 1067.17M 848.86M 597.53M 575.36M
Ebitda 1390.06M 1400.95M 1124.81M 754.11M -
Depreciation and amortization 345.58M 333.78M 275.95M 156.57M -
Non operating income net other - - - - -
Operating income 1044.48M 1067.17M 848.86M 597.53M 513.19M
Other operating expenses 268.90M 474.88M 477.60M 258.64M -
Interest expense - 0.00000M 0.00000M 0.00000M 0.00000M
Tax provision - 73.95M 31.06M -2.62100M 0.93M
Interest income - 366.56M 336.49M 227.88M 223.27M
Net interest income - - - - -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 55.90M 73.95M 31.06M 2.62M 0.93M
Total revenue 1583.65M 1573.16M 1269.65M 870.25M 784.52M
Total operating expenses 223.20M 435.78M 452.71M 234.65M -
Cost of revenue 45.70M 39.10M 24.89M 23.99M 9.24M
Total other income expense net -84.76400M -336.28400M -385.52900M -223.75200M -
Discontinued operations - - - - -
Net income from continuing ops - - - - -
Net income applicable to common shares 901.00M 653.86M 429.35M 372.38M 1013.00M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 19658.00M 20519.80M 16829.01M 14467.33M 8843.64M
Intangible assets 1209.50M 1278.59M 1193.73M 556.66M -
Earning assets - - - - -
Other current assets 506.13M 1252.62M 938.08M 625.31M 61.76M
Total liab 11063.59M 12074.13M 9485.16M 7439.18M 4296.53M
Total stockholder equity 8592.84M 8440.19M 7338.53M 7028.05M 4547.11M
Deferred long term liab 12.04M 5.49M 0.19M 2.49M 4.79M
Other current liab 8.87M 4.20M 51.30M 5.60M -
Common stock 0.60M 0.60M 0.54M 0.52M 0.37M
Capital stock - - - - -
Retained earnings 116.28M -87.69100M -71.41100M 83.01M 162.77M
Other liab 70.33M 96.41M 89.01M 45.72M 40.99M
Good will - - - - -
Other assets 632.58M 450.43M 416.20M 1484.28M 1333.53M
Cash 235.67M 459.23M 549.88M 1462.29M 820.87M
Cash and equivalents - - - - -
Total current liabilities 630.20M 607.79M 438.75M 291.49M 204.32M
Current deferred revenue - - - - -
Net debt -235.66800M -459.22700M -549.88400M -1462.28600M -
Short term debt - - - - -
Short long term debt - - - - -
Short long term debt total - 11282.77M 8867.39M 7025.61M 4037.39M
Other stockholder equity 8475.96M 8527.28M 7337.99M 6944.52M -58.20200M
Property plant equipment 11485.83M 11798.49M 10059.90M 6985.91M 4450.99M
Total current assets 3387.32M 4549.93M 4035.56M 4513.48M 2186.58M
Long term investments - - - - -
Net tangible assets 7383.34M 7161.60M 6144.80M 6471.38M 4194.62M
Short term investments - - - - -
Net receivables 2645.52M 2838.08M 2547.59M 2425.89M 1303.95M
Long term debt - 11282.77M 8865.46M 7023.68M 4037.39M
Inventory - - 0.00000M - -
Accounts payable 621.32M 603.59M 387.45M 285.89M 204.32M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - -0.77700M -0.77700M -0.77700M -0.77700M
Accumulated amortization - - - - -
Non currrent assets other -15638.10300M -15519.44100M -12377.25500M -8469.56800M -
Deferred long term asset charges - - - - -
Non current assets total 15638.10M 15519.44M 12377.25M 8469.57M -
Capital lease obligations - - - - -
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments 14.29M 65.55M 69.22M 69.22M 69.22M
Change to liabilities 33.62M 41.36M 1.40M 45.21M -5.45100M
Total cashflows from investing activities 396.06M -3858.41300M -2946.77300M -4883.95700M 564.18M
Net borrowings -537.49400M 2576.53M 1578.58M 2982.69M -51.98300M
Total cash from financing activities -1342.52300M 2947.61M 1401.07M 5041.88M -345.87000M
Change to operating activities -4.02900M -4.37500M 18.26M -4.99200M -18.05100M
Net income 902.60M 656.02M 431.45M 374.68M 1016.68M
Change in cash -220.34400M -94.48700M -911.62200M 645.57M 650.18M
Begin period cash flow 461.88M 556.37M 1467.99M 822.42M -
End period cash flow 241.54M 461.88M 556.37M 1467.99M 822.42M
Total cash from operating activities 739.01M 811.66M 617.64M 494.12M 449.09M
Issuance of capital stock - - - - -
Depreciation 345.58M 333.78M 275.95M 156.57M 141.49M
Other cashflows from investing activities - - 1370.76M -234.56500M 2049.14M
Dividends paid 698.53M 643.47M 567.97M 411.70M 363.91M
Change to inventory - - - - -
Change to account receivables -116.42000M -23.86700M -2.43800M 12.91M 46.50M
Sale purchase of stock -47.86200M - 411.10M 2533.21M 94.24M
Other cashflows from financing activities 273.48M 4982.07M 2769.04M 5519.32M -24.22000M
Change to netincome -439.37900M -208.12100M -120.08700M -99.14800M -739.44800M
Capital expenditures 0.00000M 0.00000M 4317.53M 4649.39M 1484.96M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -116.42000M -23.86700M -2.43800M 12.91M 22.85M
Stock based compensation 49.42M 52.11M 47.15M 32.19M -
Other non cash items -442.16500M -206.38900M -134.48300M -82.23600M -
Free cash flow 739.01M 811.66M 617.64M 494.12M -

Peer Comparison

Sector: Industry:

Company Change (GBP) Price (GBP) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x)
0JZZ
Medical Properties Trust Inc.
0.12 3.02% 4.26 0.03 - 0.01 -
0M69
OTP Bank Nyrt
8500.00 67.51% 21090.00 - - - -
0RUK
MOL Hungarian Oil & Gas PLC
-270.0 9.24% 2652.00 - - - -
0RIH
Alphabet Inc Class A
-2.4 1.36% 174.55 - - - -
0M2Z
Equinor ASA
-0.473 0.18% 267.78 - - - -

Reports Covered

Stock Research & News

Profile

Medical Properties Trust, Inc. is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023. Since the end of the third quarter, the Company has sold four facilities and now owns approximately 43,000 licensed beds in nine countries across three continents. MPT's financing model facilitates acquisitions and recapitalizations and allows operators of hospitals to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.

Medical Properties Trust Inc.

1000 Urban Center Drive, Birmingham, AL, United States, 35242

Key Executives

Name Title Year Born
Mr. Edward K. Aldag Jr. Founder, Chairman, Pres & CEO 1964
Mr. Emmett E. McLean Founder, Exec. VP, COO & Sec. 1955
Mr. R. Steven Hamner CPA Founder, Exec. VP, CFO & Director 1957
Mr. James Kevin Hanna Chief Accounting Officer, VP & Controller 1973
Mr. Tim Berryman Managing Director of Investor Relations NA
Mr. Andrew T. Babin C.F.A. Sr. Managing Director of Corp. Communications NA
Ms. Rosa H. Hooper VP and MD of Asset Management & Underwriting NA
Mr. Jamey Ramsey Managing Director of Tax NA
Mr. R. Lucas Savage VP & Head of Global Acquisitions NA
Mr. Charles R. Lambert VP, Treasurer & MD of Capital Markets 1971

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions